New registry tracks sleep drug QUVIVIQ in pregnancy

NCT ID NCT06498128

Recruiting now Knowledge-focused Sponsor: Idorsia Pharmaceuticals Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows about 785 pregnant women with insomnia to see if taking the sleep medication QUVIVIQ affects pregnancy or baby health. Researchers will compare outcomes like birth defects and pregnancy complications between women who took QUVIVIQ and those who used other insomnia treatments or none. The goal is to gather safety information, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INSOMNIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

insomnia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INSOMNIA

Contacts and locations

Locations

Azienda Ospedaliera Universitaria Policlinico Tor Vergata
NOT_YET_RECRUITING

Rome, Italy
Charité - Universitätsmedizin Berlin
NOT_YET_RECRUITING

Berlin, Germany
Hospital Txagorritxu
NOT_YET_RECRUITING

Vitoria-Gasteiz, Spain
Hôpital Gui de Chauliac
NOT_YET_RECRUITING

Montpellier, France
IQVIA US Office
RECRUITING

Durham, North Carolina, 27703, United States
Jodha Tishon
NOT_YET_RECRUITING

Toronto, Ontario, Canada
University College London Hospitals
NOT_YET_RECRUITING

London, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.